Patient Registry of Posner-Schlossman Syndrome
1 other identifier
observational
180
1 country
1
Brief Summary
Posner-Schlossman syndrome, or glaucomatocyclitic crisis, is a condition characterized by recurrent, acute attacks of mild, nongranulomatous, anterior uveitis accompanied by markedly elevated intraocular pressure. Most of patients are the 20 to 50-year-old young adults, with unilateral eye involvement. PSS was originally deemed benign, but is now recognized as a relatively rare cause of chronic secondary glaucoma,especially in patients with recurrent episodes. This relatively rare disease is likely the result of the infections of a variety of organisms, and the bulk of literature supports the cytomegalovirus (CMV) as the leading cause. This study is an observational study that does not interfere with the normal clinical diagnosis and treatment process. The investigators in this study focus on observing the clinical symptoms and outcome of PSS, analyzing the factors that affect the prognosis of PSS, studying the association of its pathogenesis with the psychological status and the behavioral types of PSS patients; exploring the relationship between infection (CMV, HSV, Hp) and PSS; and studying the changes of local and systemic cytokine expression and its significance in patients with PSS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 31, 2014
CompletedFirst Submitted
Initial submission to the registry
July 22, 2017
CompletedFirst Posted
Study publicly available on registry
July 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedOctober 14, 2020
October 1, 2020
10 years
July 22, 2017
October 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
demographic characteristics
age, sex, education level, systemic disease, mental state
up to 10 years
visual acuity
uncorrected visual acuity and best corrected visual acuity
up to 10 years
intraocular pressure
Goldmann
up to 10 years
slit-lamp examination
anterior segment
up to 10 years
fundus photograph
analysis the morphology of optic nerve head
up to 10 years
OCT
zess
up to 10 years
visual field
Humphrey visual field
up to 10 years
blood serum
8ml
up to 10 years
aqueous humor
0.2ml
up to 10 years
tissue
iris and\& or trabecular meshwork tissue abandoned in the anti-glaucoma operation
in the operation
Study Arms (3)
Posner-Schlossman Syndrome
Inclusion criteria: * Clinical diagnosis of Posner-Schlossman Syndrome * Able to communicate with doctor and understand this study Exclusion criteria: * Not be able to communicate with doctor and understand this study * One or more authorized investigators think he or she will suffer from any severe risks from the study
cataract
Inclusion criteria: * Clinical diagnosis of age-related cataract * Prepare for cataract operation * Open angle and intraocular pressure is normally at anytime * No family history of glaucoma Exclusion criteria: * Patients above 65 years old * With Secondary ocular hypertension * Have the history of receiving any ophthalmologic operation or anti-viral therapy * With diabetes mellitus * With autoimmune disease * Be receiving any therapy that can influence the virus-infection state and biochemical characteristics of serum and aqueous humor, or have received such therapy before one month
primary open-angle glaucoma
Inclusion criteria: * Both eyes involved * Open angle * Progressive glaucomatous optic neuropathy * Specific visual field loss of glaucoma * Intraocular pressure above the up limit of normal people Exclusion criteria: * Patients above 65 years old * With Secondary ocular hypertension * Have the history of receiving any ophthalmologic operation or anti-viral therapy * With diabetes mellitus * With autoimmune disease * Be receiving any therapy that can influence the virus-infection state and biochemical characteristics of serum and aqueous humor, or have received such therapy before one month
Eligibility Criteria
All the patients that visit the Peking University Third Hospital from July 2014 to July 2019 and are diognosed as Posner-Schlossman Syndrome, age-related cataract, or primary open-angle glaucoma.
You may qualify if:
- Volunteer to take part in this study and sign informed consent by oneself or the patient's legal representative
- Clinical diagnosis of Posner-Schlossman Syndrome, age-related cataract, or primary open-angle glaucoma
- Live in Beijing, China or being able to visit the Peking University Third Hospital every year after the beginning of the study or whenever the disease relapses
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Third Hosipital
Beijing, Beijing Municipality, 100191, China
Biospecimen
serum, aqueous humor,iris,trabecular meshwork
Study Officials
- STUDY DIRECTOR
Chun Zhang, PHD,MD
Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 22, 2017
First Posted
July 28, 2017
Study Start
July 31, 2014
Primary Completion
July 31, 2024
Study Completion
July 31, 2024
Last Updated
October 14, 2020
Record last verified: 2020-10